• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children.

作者信息

Wintergerst U, Engelhorn C, Kurowski M, Hoffmann F, Notheis G, Belohradsky B H

机构信息

Department of Infectious Diseases and Immunology, Children's Hospital of the Ludwig-Maximilians University, Munich, Germany.

出版信息

AIDS. 2000 Aug 18;14(12):1866-8. doi: 10.1097/00002030-200008180-00030.

DOI:10.1097/00002030-200008180-00030
PMID:10985332
Abstract
摘要

相似文献

1
Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children.安普那韦与依法韦仑或地拉韦啶联用在HIV感染儿童中的药代动力学相互作用
AIDS. 2000 Aug 18;14(12):1866-8. doi: 10.1097/00002030-200008180-00030.
2
Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected children.
AIDS. 2004 Jul 2;18(10):1473-5. doi: 10.1097/01.aids.0000131342.53419.4d.
3
Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.在血清阴性个体中添加奈非那韦、茚地那韦、利托那韦或沙奎那韦之前及之后的安普那韦和依非韦伦药代动力学。
Antimicrob Agents Chemother. 2005 Aug;49(8):3373-81. doi: 10.1128/AAC.49.8.3373-3381.2005.
4
Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.健康志愿者多次给药后安普那韦与地拉韦啶之间的药代动力学相互作用。
Br J Clin Pharmacol. 2003 Jan;55(1):100-6. doi: 10.1046/j.1365-2125.2003.01734.x.
5
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.奈非那韦和依非韦伦在未接受过抗逆转录病毒治疗的人类免疫缺陷病毒感染受试者中单独给药或与核苷类逆转录酶抑制剂联合给药时的药代动力学。
Antimicrob Agents Chemother. 2005 Aug;49(8):3558-61. doi: 10.1128/AAC.49.8.3558-3561.2005.
6
Delavirdine increases drug exposure of ritonavir-boosted protease inhibitors.
AIDS. 2002 Mar 29;16(5):798-9. doi: 10.1097/00002030-200203290-00019.
7
Pharmacokinetic interaction between amprenavir and delavirdine: evidence of induced clearance by amprenavir.安普那韦与地拉韦啶之间的药代动力学相互作用：安普那韦诱导清除的证据。
Clin Pharmacol Ther. 2002 Dec;72(6):615-26. doi: 10.1067/mcp.2002.128868.
8
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity.在接受蛋白酶抑制剂治疗方案失败的人类免疫缺陷病毒（HIV）感染患者中，使用安普那韦、阿巴卡韦和依非韦伦进行联合治疗：药代动力学药物相互作用及抗病毒活性
Clin Infect Dis. 2000 Feb;30(2):313-8. doi: 10.1086/313667.
9
Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis.接受持续性非卧床腹膜透析患者的依非韦伦给药剂量。
AIDS. 2000 May 26;14(8):1062-4. doi: 10.1097/00002030-200005260-00021.
10
Dose-dependent pharmacokinetics of delavirdine in combination with amprenavir in healthy volunteers.
J Antimicrob Chemother. 2004 Jul;54(1):206-10. doi: 10.1093/jac/dkh252. Epub 2004 May 18.

引用本文的文献

1
Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients.硫酸茚地那韦和去羟肌苷在 HIV 感染患者中的多次剂量药代动力学。
Clin Drug Investig. 2003;23(5):323-8. doi: 10.2165/00044011-200323050-00002.
2
Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.食物对 HIV 感染患者稳态下地拉韦啶药代动力学的影响。
Clin Drug Investig. 2003;23(4):255-61. doi: 10.2165/00044011-200323040-00005.
3
Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.
抗逆转录病毒疗法在HIV-1感染儿童中的药代动力学
Clin Pharmacokinet. 2005;44(9):935-56. doi: 10.2165/00003088-200544090-00004.
4
Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.健康志愿者多次给药后安普那韦与地拉韦啶之间的药代动力学相互作用。
Br J Clin Pharmacol. 2003 Jan;55(1):100-6. doi: 10.1046/j.1365-2125.2003.01734.x.
5
Antiretroviral pharmacokinetics in the paediatric population: a review.儿科人群中的抗逆转录病毒药物动力学：综述
Clin Pharmacokinet. 2002;41(14):1115-33. doi: 10.2165/00003088-200241140-00001.
6
Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors.非核苷类逆转录酶抑制剂的临床药代动力学
Clin Pharmacokinet. 2001;40(12):893-905. doi: 10.2165/00003088-200140120-00002.
7
The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.非核苷类逆转录酶抑制剂在HIV-1感染儿童中的作用。
Paediatr Drugs. 2001;3(9):681-702. doi: 10.2165/00128072-200103090-00006.
8
Delavirdine: clinical pharmacokinetics and drug interactions.地拉韦啶：临床药代动力学与药物相互作用
Clin Pharmacokinet. 2001;40(3):207-26. doi: 10.2165/00003088-200140030-00005.
9
Delavirdine: a review of its use in HIV infection.地拉韦啶：其在HIV感染治疗中的应用综述
Drugs. 2000 Dec;60(6):1411-44. doi: 10.2165/00003495-200060060-00013.
10
Amprenavir: a review of its clinical potential in patients with HIV infection.安普那韦：对其在HIV感染患者中的临床潜力的综述。
Drugs. 2000 Dec;60(6):1383-410. doi: 10.2165/00003495-200060060-00012.